ELRANATAMAB
Elranatamab 76 mg/1.9 mL injection, 1.9 mL vial
ELRANATAMAB (15331X)
15331X
Manner of administration:Injection
Restriction
Indication: Relapsed or refractory multiple myeloma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $6,038.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Elrexfio | |||||